<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
 <head>
 </head>
 <body>
  <h1>
   Upsher-Smith Laboratories, Inc.
  </h1>
  <div style="display: none;">
   <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <thead>
     <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
     </tr>
    </thead>
    <tbody>
     <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       047251004
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       109576
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       2
      </td>
     </tr>
    </tbody>
   </table></div><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" /><p>
   Upsher-Smith Laboratories (U-S) makes drugs that include branded and generic prescription and over-the-counter medications focused on cardiology, dermatology, women's health, and diseases of the central nervous system. Its cardiology products include folic acid supplement Folgard, anticoagulant Jantoven, and controlled-release supplement Slo-Niacin. Its dermatology line includes moisturizers and cleansers under the Clenia brand name, and its women's health products include prenatal and nutritional supplements, hormones, and an antifungal. Controlled by the Evenstad family, U-S is also pursuing investigational therapies for epilepsy, Parkinson's disease, and Alzheimer's disease.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Operations.flsnp" />
  <p>
   The company has a particular focus on developing treatments for people living with conditions of the central nervous system, such as seizure disorders. Subsidiary Proximagen is a European biotechnology firm, also focusing on central nervous system disorders as well as oncology, inflammation, and obesity.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Geographic Reach.flsnp" />
  <p>
   U-S maintains two facilities in the greater Minneapolis area -- one in Morristown, New Jersey, and another in Denver. It also has operations in the UK.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Sales and Marketing.flsnp" />
  <p>
   U-S operates two educational websites for health care professionals. Its Epilog.us site is dedicated to epilepsy and its treatment, offering current data and expert insights as well as exploring modern therapy issues. Meanwhile, its Clinicians Corner site is dedicated to women's health by providing resources and educational materials for advanced practice clinicians.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Strategy.flsnp" />
  <p>
   To build up its range of products and leverage its formulation development competency, U-S actively seeks alliances and co-development programs along with licensing and acquisition opportunities. It has partnered with larger pharmaceutical companies, carrying products through clinical trials and launching new products through licensing agreements.
  </p>
  <p>
   As part of its long-term strategy to advance its current product portfolio of branded drugs, the company's UK subsidiary Proximagen is partnering with Denmark-based
   <company id="147681">
    H. Lundbeck A/S
   </company>
   to further its preclinical research program related to developing protein kinase inhibitors.
  </p>
  <p>
   Proximagen entered another collaboration in 2016: It is working with biotech Saniona to research new small molecule therapies using Saniona's expertise in ion channels. In 2014, U-S entered into a potassium chloride manufacturing, supply, and distribution agreement with
   <company id="103281">
    Sandoz
   </company>
   (part of its efforts to get its potassium chloride products to a wider market).
  </p>
  <p>
   Furthering its efforts to focus on generics and novel therapies, U-S sold its AmLactin brand of skin care products to Sandoz in late 2016. Terms of the deal were not disclosed.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Mergers and Acquisitions.flsnp" />
  <p>
   In October 2016, U-S acquired 20
   <company id="144161">
    FDA
   </company>
   -approved generic products from Sandoz for an undisclosed amount. The purchase furthers its strategy to expand its generics portfolio.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Company Background.flsnp" />
  <p>
   Ken Evenstad, who serves as chairman of U-S, also founded Oregon-based Domaine Serene Vineyards and Winery with his wife Grace in 1989. Their son, Mark, serves as president and CEO of U-S.
  </p>
  <p>
   The company was founded in 1919 by UK-trained chemist F.A. Upsher Smith.
  </p>
 <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /></body>
</html>
